Dongwook Kim

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

George R. Blumenschein, Egbert F. Smit, David Planchard et al. · Annals of Oncology · 2015 · 355 citations · Full text

Non-small-cell Lung Cancer, Medicine, Pharmacology +10

Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer

Dongwook Kim, Sun‐Young Kim, H.-K. Kim et al. · Annals of Oncology · 2007 · 348 citations · Full text

Polymer-drug Conjugate, Medicine, Pharmacology +6

Random Circuit Breaker Network Model for Unipolar Resistance Switching

Seung Chul Chae, Jae Sung Lee, Se‐Jin Kim et al. · Advanced Materials · 2008 · 344 citations

Electrical Engineering, Engineering, Smart Grid +13

Nearly room temperature ferromagnetism in a magnetic metal-rich van der Waals metal

Junho Seo, Duck Young Kim, Eun Su An et al. · Science Advances · 2020 · 303 citations · Full text

Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS

Yi‐Long Wu, D. Planchard, Shun Lü et al. · Annals of Oncology · 2018 · 291 citations · Full text